1. Home
  2. DVA vs CNM Comparison

DVA vs CNM Comparison

Compare DVA & CNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • CNM
  • Stock Information
  • Founded
  • DVA 1994
  • CNM 1996
  • Country
  • DVA United States
  • CNM United States
  • Employees
  • DVA N/A
  • CNM N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • CNM Durable Goods
  • Sector
  • DVA Health Care
  • CNM Consumer Discretionary
  • Exchange
  • DVA Nasdaq
  • CNM Nasdaq
  • Market Cap
  • DVA 10.9B
  • CNM 10.8B
  • IPO Year
  • DVA 1995
  • CNM 2021
  • Fundamental
  • Price
  • DVA $142.56
  • CNM $62.33
  • Analyst Decision
  • DVA Hold
  • CNM Buy
  • Analyst Count
  • DVA 4
  • CNM 11
  • Target Price
  • DVA $157.00
  • CNM $59.55
  • AVG Volume (30 Days)
  • DVA 857.4K
  • CNM 2.5M
  • Earning Date
  • DVA 08-05-2025
  • CNM 06-10-2025
  • Dividend Yield
  • DVA N/A
  • CNM N/A
  • EPS Growth
  • DVA 14.90
  • CNM 1.17
  • EPS
  • DVA 10.11
  • CNM 2.16
  • Revenue
  • DVA $12,968,524,000.00
  • CNM $7,611,000,000.00
  • Revenue This Year
  • DVA $6.46
  • CNM $6.11
  • Revenue Next Year
  • DVA $3.24
  • CNM $5.31
  • P/E Ratio
  • DVA $14.10
  • CNM $28.86
  • Revenue Growth
  • DVA 5.11
  • CNM 10.80
  • 52 Week Low
  • DVA $131.76
  • CNM $37.22
  • 52 Week High
  • DVA $179.60
  • CNM $62.47
  • Technical
  • Relative Strength Index (RSI)
  • DVA 55.72
  • CNM 72.78
  • Support Level
  • DVA $135.07
  • CNM $59.45
  • Resistance Level
  • DVA $147.45
  • CNM $59.73
  • Average True Range (ATR)
  • DVA 3.05
  • CNM 1.24
  • MACD
  • DVA 0.82
  • CNM 0.30
  • Stochastic Oscillator
  • DVA 61.83
  • CNM 98.09

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About CNM Core & Main Inc.

Core & Main Inc is a specialty distributor focusing on water, wastewater, storm drainage, and fire protection products and services. Catering to municipalities, private water companies, and contractors, it serves municipal, non-residential, and residential markets nationwide. Its diverse product line includes pipes, valves, fittings, storm drainage products, fire protection products, and meter products. Revenue is principally generated from pipes, valves, and fittings. The company operates across three construction sectors: municipal, non-residential, and residential, contributing to reliable infrastructure development nationwide.

Share on Social Networks: